Skip to main content

Advertisement

Log in

Validation of the ACR/EULAR classification criteria for systemic sclerosis in patients with early scleroderma

  • Validation Studies
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The aim of this study was to validate the 2013 ACR/EULAR classification criteria for systemic sclerosis (SSc) in patients with SSc, including patients with early SSc. Fifty-six consecutive patients with early SSc (2001 LeRoy and Medsger criteria), 122 patients with established SSc (1980 ACR classification criteria), and 141 patients with SSc-like disorders were included in this cross-sectional study. The diagnostic performance of the 2013 ACR/EULAR criteria was compared with the 1980 ACR criteria in several subsets of patients. The performance of individual variables was also obtained. Receiver operating characteristic (ROC) curves and optimal cut-off values were computed. The sensitivity and specificity in the whole cohort of 178 SSc patients were 77.6 and 98.5%, respectively, using the 2013 ACR/EULAR criteria and 68.5 and 100%, respectively, using the 1980 ACR criteria. Twenty-eight percent of the patients with early SSc met the 2013 ACR/EULAR criteria. Among the patients with early SSc, 53% of those who had Raynaud’s phenomenon, abnormal capillaroscopy and positive SSc-related antibodies met the 2013 ACR/EULAR criteria. The area under the ROC curve was 0.975 (95% confidence interval 0.962–0.987). The best cut-off value for the total score was ≥8 (sensitivity 82%; specificity 97.9%). The individual variables with the highest specificity values were proximal skin thickening, sclerodactyly (specificity 100%), telangiectasia and SSc-related antibodies (specificity 98.6%). Raynaud’s phenomenon had the best sensitivity (99.4%) but had low specificity (4.2%). In conclusion, the 2013 ACR/EULAR classification criteria showed high accuracy and increased sensitivity in the classification of patients with early SSc.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Johnson SR, Fransen J, Khanna D et al (2012) Validation of potential classification criteria for systemic sclerosis. Arthritis Care Res 64:358–367

    Article  Google Scholar 

  2. Assassi S, Del Junco D, Sutter K et al (2009) Clinical and genetic factors predictive of mortality in early systemic sclerosis. Arthritis Rheum 61:1403–1411

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205

    CAS  PubMed  Google Scholar 

  4. Bellando-Randone S, Guiducci S, Matucci-Cerinic M (2012) Very early diagnosis of systemic sclerosis. Pol Arch Med Wewn 122(Suppl 1):18–23

    PubMed  Google Scholar 

  5. Herrick AL (2005) Pathogenesis of Raynaud’s phenomenon. Rheumatology 44:587–596

    Article  CAS  PubMed  Google Scholar 

  6. Masi AT and Subcommittee For Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590

    Article  Google Scholar 

  7. LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28:1573–1576

    CAS  PubMed  Google Scholar 

  8. van den Hoogen F, Khanna D, Fransen J et al (2013) Classification criteria for systemic sclerosis: an ACR-EULAR collaborative initiative. Arthritis Rheum 65:2737–2747

    Article  PubMed  PubMed Central  Google Scholar 

  9. Lonzetti LS, Joyal F, Raynauld JP et al (2001) Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 44:735–736

    Article  CAS  PubMed  Google Scholar 

  10. Wigley FM (2001) When is scleroderma really scleroderma? J Rheumatol 28:1471–1473

    CAS  PubMed  Google Scholar 

  11. Koenig M, Joyal F, Fritzler MJ et al (2008) Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud’s phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 58(12):3902–3912

    Article  PubMed  Google Scholar 

  12. Cutolo M, Grassi W, Matucci Cerinic M (2003) Raynaud’s phenomenon and the role of capillaroscopy. Arthritis Rheum 48:3023–3030

    Article  PubMed  Google Scholar 

  13. Avouac J, Fransen J, Walker UA et al (2011) Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis 70(3):476–481

    Article  CAS  PubMed  Google Scholar 

  14. Nadashkevich O, Davis P, Fritzler MJ (2004) A proposal of criteria for the classification of systemic sclerosis. Med Sci Monit 10(11):615–621

    Google Scholar 

  15. Masi AT, Medsger TA Jr (2015) Progress in the evolution of systemic sclerosis classification criteria and recommendation for additional comparative specificity studies. J Rheumatol 42:8–10

    Article  PubMed  Google Scholar 

  16. LeRoy EC, Medsger TA Jr (1992) Raynaud’s phenomenon: a proposal for classification. Clin Exp Rheumatol 10(5):485–488

    CAS  PubMed  Google Scholar 

  17. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725

    Article  CAS  PubMed  Google Scholar 

  18. Boham A, Peter JB (1975) Polymyositis and dermatomyositis. N Engl J Med 292:344–347

    Article  Google Scholar 

  19. Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Alarcon-Segovia D, Cardiel MH (1989) Comparison between three diagnostic criteria for mixed connective tissue disease. Studies of 593 patients. J Rheumatol 16:328–334

    CAS  PubMed  Google Scholar 

  21. Andrade LE, Gabriel Júnior A, Assad RL, Ferrari AJ, Atra E (1990) Panoramic nailfold capillaroscopy: a new reading method and normal range. Semin Arthritis Rheum 20:21–31

    Article  CAS  PubMed  Google Scholar 

  22. Sekiyama JY, Camargo CZ, Andrade LEC, Kayser C (2013) Reliability of widefield nailfold capillaroscopy and video capillaroscopy in the assessment of patients with Raynaud’s phenomenon. Arthritis Care Res 65:1853–1861

    Article  Google Scholar 

  23. Maricq HR, LeRoy EC (1973) Patterns of finger capillary abnormalities in connective tissue disease by “wide-field” microscopy. Arthritis Rheum 16:619–628

    Article  CAS  PubMed  Google Scholar 

  24. Jordan S, Maurer B, Toniolo M, Michel B, Distler O (2015) Performance of the new ACR/EULAR classification criteria for systemic sclerosis in clinical practice. Rheumatology 54:1454–1458

    Article  PubMed  Google Scholar 

  25. Sáez-Comet L, Simeón-Aznar CP, Pérez-Conesa M et al (2015) Applying the ACR/EULAR systemic sclerosis classification criteria to the spanish scleroderma registry cohort. J Rheumatol 42:2327–2331

    Article  PubMed  Google Scholar 

  26. Luggen M, Belhorn L, Evans T et al (1995) The evolution of Raynaud’s phenomenon: a longterm prospective study. J Rheumatol 22:2226–2232

    CAS  PubMed  Google Scholar 

  27. Minier T, Guiducci S, Bellando-Randone S et al (2014) Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis. Ann Rheum Dis 73:2087–2093

    Article  PubMed  Google Scholar 

  28. Alhajeri H, Hudson M, Fritzler M et al (2015) 2013 American College of Rheumatology/European League against rheumatism classification criteria for systemic sclerosis outperform the 1980 criteria: data from the Canadian Scleroderma Research Group. Arthritis Care Res 67:582–587

    Article  Google Scholar 

  29. Park J-S, Park M-C, Song JJ, Park Y-B, Lee S-K, Lee S-W (2015) Application of the 2013 ACR/EULAR classification criteria for systemic sclerosis to patients with Raynaud’s phenomenon. Arthritis Res Ther 17(1):77

    Article  PubMed  PubMed Central  Google Scholar 

  30. Valentini G, Marcoccia A, Cuomo G et al (2014) Early systemic sclerosis: analysis of the disease course in patients with marker autoantibody and/or capillaroscopic positivity. Arthritis Care Res 66(10):1520–1527

    Article  Google Scholar 

  31. Valentini G, Marcoccia A, Cuomo G, Iudici M, Vettori S (2014) The concept of early systemic sclerosis following 2013 ACR\EULAR criteria for the classification of systemic sclerosis. Curr Rheumatol Rev 10(1):38–44

    Article  PubMed  Google Scholar 

  32. Hoffmann-Vold AM, Gunnarsson R, Garen T, Midtvedt Ø, Molberg Ø (2015) Performance of the 2013 American College of Rheumatology/European League against rheumatism classification criteria for systemic sclerosis (SSc) in large, well-defined cohorts of SSc and mixed connective tissue disease. J Rheumatol 42:60–63

    Article  PubMed  Google Scholar 

  33. Pamuk ON, Balci MA, Onat AM, Zengin O, Cakir N, Kisacik B (2016) Performance of the new American College of Rheumatology classification criteria in Turkish systemic sclerosis patients: a multicenter study. Clin Rheumatol 35(2):357–361

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cristiane Kayser.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Araújo, F.C., Camargo, C.Z. & Kayser, C. Validation of the ACR/EULAR classification criteria for systemic sclerosis in patients with early scleroderma. Rheumatol Int 37, 1825–1833 (2017). https://doi.org/10.1007/s00296-017-3787-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-017-3787-1

Keywords

Navigation